This Project Grant award, with a total funding amount of $1,540,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to Colorado State University (CSU) on March 1, 2025, with a performance period through February 29, 2028. The objective of this award is to develop a Multifunctional Medical Foam (MF) to enhance acute wound management in situ. CSU, through its Sponsored Programs division, will leverage...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
The U.S. Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $749,343 project grant to New York University (NYU) on August 1, 2025. The grant supports a 2-year research project titled "P15-1 PEPTIDE TREATMENT FOR CARTILAGE INJURIES AND POST-TRAUMATIC OSTEOARTHRITIS" to be completed by July 31, 2027. Through this funding, NYU will conduct advanced biomedical research to develop innovative treatments for cartilage injuries and...
The federal Project Grant award of $505,228.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award is titled "TOWARD PRESERVING KNEE JOINT HEALTH AFTER LOWER LIMB LOSS INVESTIGATING JOINT LEVEL PATHOMECHANICS WITH SIMULATED AMBULATION" and aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to The Henry...
This federal Project Grant award of $749,378.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the Trustees of Indiana University, doing business as Indiana University, to investigate the systemic administration of STO-609 to prevent post-traumatic osteoarthritis in a translational porcine intraarticular fracture model. The research aims to transform healthcare for military service members, veterans, and the broader...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,000,000.00 in funding to Tekhona Inc., a for-profit S corporation, to develop intra-articular immunoregulatory microparticles for inducing systemic remission in rheumatoid arthritis. The 2-year research project, with an award date of September 15, 2023 and an ultimate completion date of September 14, 2025, aims to transform healthcare for Service...
This $298,329 federal Project Grant awarded by the Defense Health Agency on March 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Arkansas for Medical Sciences (UAMS) on the role of subchondral bone osteocytes in post-traumatic osteoarthritis. UAMS, a major academic medical center, will leverage its expertise in biomedical research to investigate this specific aspect of osteoarthritis development over the 2-year award...
The Department of the Army Medical Command awarded a $2,756,800 Project Grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The award will support development of an implantable device that enables personalized, sustained release of bioagents for large bone defect reconstruction and limb salvage from June 2022 through May 2026. Under the award, Stanford will establish a sheep bone transport model and test handling of a novel intramedullary...
The federal Project Grant award of $500,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Washington University to accelerate the diagnosis of inflammatory arthritis. The project aims to harness single-cell T cell-receptor sequencing to develop innovative diagnostic approaches. The research is being conducted at Washington University's Office of Sponsored Research Services Division over a 2-year performance period from...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...